مصطلحات الفهرس: parkinsonism/si [Side Effect], positive syndrome/dt [Drug Therapy], psychosis/dt [Drug Therapy], retrospective study, schizophrenia/dt [Drug Therapy], sedation, side effect/si [Side Effect], transient ischemic attack/si [Side Effect], treatment duration, unspecified side effect/si [Side Effect], weight gain, atypical antipsychotic agent/ae [Adverse Drug Reaction], atypical antipsychotic agent/dt [Drug Therapy], cholinergic receptor blocking agent, clozapine/ae [Adverse Drug Reaction], clozapine/dt [Drug Therapy], olanzapine/dt [Drug Therapy], risperidone/ae [Adverse Drug Reaction], risperidone/do [Drug Dose], risperidone/dt [Drug Therapy], risperidone/po [Oral Drug Administration], olanzapine/ae [Adverse Drug Reaction], akathisia/si [Side Effect], Alzheimer disease, Australia, drug dose titration, drug efficacy, extrapyramidal symptom/si [Side Effect], geriatric patient, heart disease/si [Side Effect], human, letter, mental health service, negative syndrome/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31910
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug withdrawal, gastrointestinal symptom/si [Side Effect], human, nephrotoxicity/si [Side Effect], neuroimaging, nonhuman, nuclear magnetic resonance imaging, practice guideline, priority journal, remission, salvage therapy, serology, side effect/si [Side Effect], treatment outcome, unspecified side effect/si [Side Effect], amphotericin B/cb [Drug Combination], amphotericin B/dt [Drug Therapy], amphotericin B deoxycholate/ae [Adverse Drug Reaction], amphotericin B deoxycholate/cb [Drug Combination], amphotericin B deoxycholate/dt [Drug Therapy], amphotericin B lipid complex/ae [Adverse Drug Reaction], amphotericin B lipid complex/cb [Drug Combination], amphotericin B lipid complex/dt [Drug Therapy], fluconazole/cb [Drug Combination], fluconazole/dt [Drug Therapy], itraconazole/ae [Adverse Drug Reaction], itraconazole/cb [Drug Combination], itraconazole/dt [Drug Therapy], voriconazole/ct [Clinical Trial], voriconazole/cb [Drug Combination], voriconazole/dt [Drug Therapy], voriconazole/po [Oral Drug Administration], voriconazole/pk [Pharmacokinetics], review, blastomycosis/di [Diagnosis], blastomycosis/dt [Drug Therapy], brain tissue, central nervous system infection/dt [Drug Therapy], central nervous system infection/di [Diagnosis], cerebrospinal fluid, clinical trial, creatinine blood level, drug efficacy, drug penetration, drug safety, drug substitution, drug use, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31364
Click here for full text options
LibKey Link

مصطلحات الفهرس: fertilization in vitro, fetus malformation/si [Side Effect], high risk population, hirsutism/dt [Drug Therapy], human, hyperandrogenism/dt [Drug Therapy], hyperandrogenism/pc [Prevention], insulin resistance/dt [Drug Therapy], insulin resistance/ep [Epidemiology], intravenous glucose tolerance test, lactic acidosis/si [Side Effect], lifestyle modification, liver toxicity/si [Side Effect], menstrual cycle, monotherapy, nausea/si [Side Effect], non insulin dependent diabetes mellitus/dt [Drug Therapy], non insulin dependent diabetes mellitus/pc [Prevention], nonhuman, ovary function, ovary polycystic disease/co [Complication], ovary polycystic disease/dt [Drug Therapy], ovulation, patch clamp, pathophysiology, pregnancy, prevalence, priority journal, review, side effect/si [Side Effect], teratogenicity/si [Side Effect], treatment indication, unspecified side effect/si [Side Effect], weight gain, weight reduction, androgen/ec [Endogenous Compound], clomifene/cb [Drug Combination], clomifene/dt [Drug Therapy], clomifene citrate/ct [Clinical Trial], clomifene citrate/cb [Drug Combination], clomifene citrate/cm [Drug Comparison], clomifene citrate/pd [Pharmacology], glitazone derivative/ae [Adverse Drug Reaction], glitazone derivative/dt [Drug Therapy], gonadorelin agonist/pd [Pharmacology], gonadotropin derivative/cb [Drug Combination], gonadotropin derivative/dt [Drug Therapy], insulin sensitizing agent/ct [Clinical Trial], insulin sensitizing agent/dt [Drug Therapy], metformin/ae [Adverse Drug Reaction], metformin/ct [Clinical Trial], metformin/cb [Drug Combination], metformin/cm [Drug Comparison], metformin/do [Drug Dose], metformin/dt [Drug Therapy], metformin/pd [Pharmacology], oral contraceptive agent/ct [Clinical Trial], oral contraceptive agent/cm [Drug Comparison], oral contraceptive agent/dt [Drug Therapy], pioglitazone/ct [Clinical Trial], pioglitazone/dt [Drug Therapy], placebo, rosiglitazone/ae [Adverse Drug Reaction], rosiglitazone/cb [Drug Combination], rosiglitazone/dt [Drug Therapy], rosiglitazone/to [Drug Toxicity], rosiglitazone/pd [Pharmacology], troglitazone/ae [Adverse Drug Reaction], troglitazone/ct [Clinical Trial], troglitazone/dt [Drug Therapy], insulin resistance/et [Etiology], anovulation/dt [Drug Therapy], birth rate, body weight, cardiovascular disease/si [Side Effect], clinical feature, clinical trial, combination chemotherapy, diabetes mellitus/dt [Drug Therapy], diabetes mellitus/pc [Prevention], diarrhea/si [Side Effect], drug dose titration, drug effect, drug mechanism, drug withdrawal, female fertility, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31793
Click here for full text options
LibKey Link

مصطلحات الفهرس: parkinsonism/si [Side Effect], positive syndrome/dt [Drug Therapy], psychosis/dt [Drug Therapy], retrospective study, schizophrenia/dt [Drug Therapy], sedation, side effect/si [Side Effect], transient ischemic attack/si [Side Effect], treatment duration, unspecified side effect/si [Side Effect], weight gain, atypical antipsychotic agent/ae [Adverse Drug Reaction], atypical antipsychotic agent/dt [Drug Therapy], cholinergic receptor blocking agent, clozapine/ae [Adverse Drug Reaction], clozapine/dt [Drug Therapy], olanzapine/dt [Drug Therapy], risperidone/ae [Adverse Drug Reaction], risperidone/do [Drug Dose], risperidone/dt [Drug Therapy], risperidone/po [Oral Drug Administration], olanzapine/ae [Adverse Drug Reaction], akathisia/si [Side Effect], Alzheimer disease, Australia, drug dose titration, drug efficacy, extrapyramidal symptom/si [Side Effect], geriatric patient, heart disease/si [Side Effect], human, letter, mental health service, negative syndrome/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31910
LibKey Link

مصطلحات الفهرس: drug withdrawal, gastrointestinal symptom/si [Side Effect], human, nephrotoxicity/si [Side Effect], neuroimaging, nonhuman, nuclear magnetic resonance imaging, practice guideline, priority journal, remission, salvage therapy, serology, side effect/si [Side Effect], treatment outcome, unspecified side effect/si [Side Effect], amphotericin B/cb [Drug Combination], amphotericin B/dt [Drug Therapy], amphotericin B deoxycholate/ae [Adverse Drug Reaction], amphotericin B deoxycholate/cb [Drug Combination], amphotericin B deoxycholate/dt [Drug Therapy], amphotericin B lipid complex/ae [Adverse Drug Reaction], amphotericin B lipid complex/cb [Drug Combination], amphotericin B lipid complex/dt [Drug Therapy], fluconazole/cb [Drug Combination], fluconazole/dt [Drug Therapy], itraconazole/ae [Adverse Drug Reaction], itraconazole/cb [Drug Combination], itraconazole/dt [Drug Therapy], voriconazole/ct [Clinical Trial], voriconazole/cb [Drug Combination], voriconazole/dt [Drug Therapy], voriconazole/po [Oral Drug Administration], voriconazole/pk [Pharmacokinetics], review, blastomycosis/di [Diagnosis], blastomycosis/dt [Drug Therapy], brain tissue, central nervous system infection/dt [Drug Therapy], central nervous system infection/di [Diagnosis], cerebrospinal fluid, clinical trial, creatinine blood level, drug efficacy, drug penetration, drug safety, drug substitution, drug use, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31364
LibKey Link

مصطلحات الفهرس: fertilization in vitro, fetus malformation/si [Side Effect], high risk population, hirsutism/dt [Drug Therapy], human, hyperandrogenism/dt [Drug Therapy], hyperandrogenism/pc [Prevention], insulin resistance/dt [Drug Therapy], insulin resistance/ep [Epidemiology], intravenous glucose tolerance test, lactic acidosis/si [Side Effect], lifestyle modification, liver toxicity/si [Side Effect], menstrual cycle, monotherapy, nausea/si [Side Effect], non insulin dependent diabetes mellitus/dt [Drug Therapy], non insulin dependent diabetes mellitus/pc [Prevention], nonhuman, ovary function, ovary polycystic disease/co [Complication], ovary polycystic disease/dt [Drug Therapy], ovulation, patch clamp, pathophysiology, pregnancy, prevalence, priority journal, review, side effect/si [Side Effect], teratogenicity/si [Side Effect], treatment indication, unspecified side effect/si [Side Effect], weight gain, weight reduction, androgen/ec [Endogenous Compound], clomifene/cb [Drug Combination], clomifene/dt [Drug Therapy], clomifene citrate/ct [Clinical Trial], clomifene citrate/cb [Drug Combination], clomifene citrate/cm [Drug Comparison], clomifene citrate/pd [Pharmacology], glitazone derivative/ae [Adverse Drug Reaction], glitazone derivative/dt [Drug Therapy], gonadorelin agonist/pd [Pharmacology], gonadotropin derivative/cb [Drug Combination], gonadotropin derivative/dt [Drug Therapy], insulin sensitizing agent/ct [Clinical Trial], insulin sensitizing agent/dt [Drug Therapy], metformin/ae [Adverse Drug Reaction], metformin/ct [Clinical Trial], metformin/cb [Drug Combination], metformin/cm [Drug Comparison], metformin/do [Drug Dose], metformin/dt [Drug Therapy], metformin/pd [Pharmacology], oral contraceptive agent/ct [Clinical Trial], oral contraceptive agent/cm [Drug Comparison], oral contraceptive agent/dt [Drug Therapy], pioglitazone/ct [Clinical Trial], pioglitazone/dt [Drug Therapy], placebo, rosiglitazone/ae [Adverse Drug Reaction], rosiglitazone/cb [Drug Combination], rosiglitazone/dt [Drug Therapy], rosiglitazone/to [Drug Toxicity], rosiglitazone/pd [Pharmacology], troglitazone/ae [Adverse Drug Reaction], troglitazone/ct [Clinical Trial], troglitazone/dt [Drug Therapy], insulin resistance/et [Etiology], anovulation/dt [Drug Therapy], birth rate, body weight, cardiovascular disease/si [Side Effect], clinical feature, clinical trial, combination chemotherapy, diabetes mellitus/dt [Drug Therapy], diabetes mellitus/pc [Prevention], diarrhea/si [Side Effect], drug dose titration, drug effect, drug mechanism, drug withdrawal, female fertility, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31793
LibKey Link

مصطلحات الفهرس: insulin/pd [Pharmacology], inwardly rectifying potassium channel subunit Kir6.2/ec [Endogenous Compound], sulfonylurea derivative/ae [Adverse Drug Reaction], sulfonylurea derivative/do [Drug Dose], sulfonylurea derivative/dt [Drug Therapy], sulfonylurea derivative/po [Oral Drug Administration], sulfonylurea receptor 1/ec [Endogenous Compound], tolbutamide/ae [Adverse Drug Reaction], tolbutamide/dt [Drug Therapy], sulfonylurea derivative/pd [Pharmacology], abdominal discomfort/si [Side Effect], absence of side effects/si [Side Effect], adolescent, adult, article, child, clinical article, clinical feature, controlled study, diabetes mellitus/dt [Drug Therapy], diabetes mellitus/et [Etiology], diarrhea/si [Side Effect], disease severity, drug dose increase, drug dose reduction, drug efficacy, drug mechanism, female, gene mutation, glycemic control, human, hypoglycemia/si [Side Effect], infant, male, nausea/si [Side Effect], pathogenesis, side effect/si [Side Effect], treatment response, unspecified side effect/si [Side Effect], glibenclamide/ae [Adverse Drug Reaction], glibenclamide/do [Drug Dose], glibenclamide/dt [Drug Therapy], gliclazide/dt [Drug Therapy], glipizide/dt [Drug Therapy], hemoglobin A1c/ec [Endogenous Compound], insulin/do [Drug Dose], insulin/dt [Drug Therapy], insulin/pa [Parenteral Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31537
Diabetes Care
Click here for full text options
LibKey Link

مصطلحات الفهرس: insulin/pd [Pharmacology], inwardly rectifying potassium channel subunit Kir6.2/ec [Endogenous Compound], sulfonylurea derivative/ae [Adverse Drug Reaction], sulfonylurea derivative/do [Drug Dose], sulfonylurea derivative/dt [Drug Therapy], sulfonylurea derivative/po [Oral Drug Administration], sulfonylurea receptor 1/ec [Endogenous Compound], tolbutamide/ae [Adverse Drug Reaction], tolbutamide/dt [Drug Therapy], sulfonylurea derivative/pd [Pharmacology], abdominal discomfort/si [Side Effect], absence of side effects/si [Side Effect], adolescent, adult, article, child, clinical article, clinical feature, controlled study, diabetes mellitus/dt [Drug Therapy], diabetes mellitus/et [Etiology], diarrhea/si [Side Effect], disease severity, drug dose increase, drug dose reduction, drug efficacy, drug mechanism, female, gene mutation, glycemic control, human, hypoglycemia/si [Side Effect], infant, male, nausea/si [Side Effect], pathogenesis, side effect/si [Side Effect], treatment response, unspecified side effect/si [Side Effect], glibenclamide/ae [Adverse Drug Reaction], glibenclamide/do [Drug Dose], glibenclamide/dt [Drug Therapy], gliclazide/dt [Drug Therapy], glipizide/dt [Drug Therapy], hemoglobin A1c/ec [Endogenous Compound], insulin/do [Drug Dose], insulin/dt [Drug Therapy], insulin/pa [Parenteral Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31537
Diabetes Care
LibKey Link

مصطلحات الفهرس: drug use, endotracheal intubation, female, gastrointestinal symptom/si [Side Effect], gestational age, home oxygen therapy, hospital admission, hospital discharge, human, incidence, infant, liquid aspiration/si [Side Effect], loading drug dose, lung dysplasia/dt [Drug Therapy], major clinical study, male, minimally invasive procedure, neonatal intensive care unit, oral mucosal disease/si [Side Effect], oxygen desaturation, oxygen saturation, oxygen therapy, pneumothorax, positive pressure ventilation, premedication, priority journal, prospective study, side effect/si [Side Effect], standard, tertiary care center, treatment duration, atropine/dt [Drug Therapy], atropine/iv [Intravenous Drug Administration], atropine/pv [Special Situation for Pharmacovigilance], caffeine/iv [Intravenous Drug Administration], caffeine/pv [Special Situation for Pharmacovigilance], poractant/ae [Adverse Drug Reaction], poractant/dt [Drug Therapy], poractant/pv [Special Situation for Pharmacovigilance], steroid, sucrose/pv [Special Situation for Pharmacovigilance], endotracheal tube, intravascular catheter, laryngoscope, stomach tube, minimally invasive surfactant therapy, drug efficacy, article, artificial ventilation, assisted ventilation, Australia, birth weight, bradycardia/dt [Drug Therapy], bradycardia/pc [Prevention], bradycardia/si [Side Effect], brain hemorrhage, child death, clinical audit, clinical observation, clinical outcome, clinician, cohort analysis, coughing/si [Side Effect], demography, drug safety, drug therapy, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27457
Journal of Pediatrics
Click here for full text options
LibKey Link

مصطلحات الفهرس: quality of life, randomized controlled trial (topic), review, treatment duration, treatment outcome, unspecified side effect/si [Side Effect], cholinesterase inhibitor/ae [Adverse Drug Reaction], cholinesterase inhibitor/ct [Clinical Trial], cholinesterase inhibitor/dt [Drug Therapy], donepezil/cb [Drug Combination], memantine/ae [Adverse Drug Reaction], memantine/ct [Clinical Trial], neuropsychiatry, memantine/dt [Drug Therapy], memantine/cb [Drug Combination], Alzheimer disease, cognition, cognition assessment, daily life activity, dementia/di [Diagnosis], dementia/dt [Drug Therapy], disease exacerbation, disease severity, drug efficacy, drug withdrawal, functional status, human, mortality, neuropsychiatric inventory, nursing home, outcome assessment, priority journal, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26787
Cochrane Database of Systematic Reviews
Click here for full text options
LibKey Link